RETRACTED: Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding
Authors:
- Renya ZhangRZRenya Zhang
Open Access
- 1 June 2021
- journal article
- retracted article
- Published by Elsevier in Molecular Therapy
- Vol. 29 (6) , 2151-2166
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 69 references indexed in Scilit:
- Deep Sequencing the MicroRNA Transcriptome in Colorectal CancerPLOS ONE, 2013
- Transgelin 2 Participates in Lovastatin-Induced Anti-Angiogenic Effects in Endothelial Cells through a Phosphorylated Myosin Light Chain-Related MechanismPLOS ONE, 2012
- Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinomaJournal of Oral Pathology & Medicine, 2011
- Histopathologic Features of the Tumor Budding in Adenocarcinoma of the Lung: Tumor Budding As an Index to Predict the Potential AggressivenessJournal of Thoracic Oncology, 2010
- Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosisJournal of Experimental & Clinical Cancer Research, 2010
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Smooth muscle 22 alpha maintains the differentiated phenotype of vascular smooth muscle cells by inducing filamentous actin bundlingLife Sciences, 2009
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- The functions of animal microRNAsNature, 2004
- Molecular cloning and expression of a smooth muscle-specific gene SM22α in zebrafishBiochemical and Biophysical Research Communications, 2003